Fairmount Healthcare Fund II L.P. insider trades

Fairmount Healthcare Fund II L.P. has filed 12 Form 4s with the SEC that we hold, for Viridian Therapeutics, Inc.\DE (VRDN) (Director, 10% owner), Spyre Therapeutics, Inc. (SYRE) (Director), Damora Therapeutics, Inc. (DMRA) (Director, 10% owner) and Jade Biosciences, Inc. (JBIO) (Director, 10% owner), among 6 companies in all. Across all of them we count 3 purchases worth $60.0M and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($20.0M) and 0 sales ($0). The largest single trade was a purchase of 1,600,000 shares of Viridian Therapeutics, Inc.\DE worth $30.0M, dated 2024-09-13. The first filing on our record is dated 2023-12-29 and the latest 2026-06-03.